Review article · 2026

Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation

Hiroshi Kawaguchi

Expert Opinion on Biological Therapy, 26(8), 737–743 · Published 27 July 2026 · DOI 10.1080/14712598.2026.2710868

View at the publisherCite this paper

In brief

“Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation” is a 2026 review article by Hiroshi Kawaguchi, published in Expert Opinion on Biological Therapy. OpenAlex counts 0 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
30
Authors
1

Abstract

INTRODUCTION: The clinical translation of pluripotent stem cell-derived therapies has entered a new phase following conditional approval of first-in-class allogeneic induced pluripotent stem cell (iPSC)-derived products in Japan. These approvals highlight both the therapeutic promise of iPSC technologies and regulatory challenges associated with evaluating complex cell-based interventions. AREAS COVERED: This report examines the evidentiary basis… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kawaguchi, H. (2026). Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation. Expert Opinion on Biological Therapy, 26(8), 737–743. https://doi.org/10.1080/14712598.2026.2710868

MLA 9

Kawaguchi, Hiroshi. “Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.” Expert Opinion on Biological Therapy, vol. 26, no. 8, 2026, pp. 737–743. https://doi.org/10.1080/14712598.2026.2710868.

Chicago

Kawaguchi, Hiroshi. 2026. “Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.” Expert Opinion on Biological Therapy 26 (8): 737–743. https://doi.org/10.1080/14712598.2026.2710868.

Harvard

Kawaguchi, H. (2026) ‘Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation’, Expert Opinion on Biological Therapy, 26(8), pp. 737–743. doi:10.1080/14712598.2026.2710868.

IEEE

H. Kawaguchi, “Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation,” Expert Opinion on Biological Therapy, vol. 26, no. 8, pp. 737–743, 2026, doi: 10.1080/14712598.2026.2710868.

BibTeX

@article{kawaguchi2026temporal,
  title     = {{Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation}},
  author    = {Kawaguchi, Hiroshi},
  journal   = {Expert Opinion on Biological Therapy},
  year      = {2026},
  volume    = {26},
  number    = {8},
  pages     = {737--743},
  doi       = {10.1080/14712598.2026.2710868},
  url       = {https://doi.org/10.1080/14712598.2026.2710868}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • genomic variation
  • manufacturing variability
  • conditional approval
  • regulatory framework
  • clinical translation
  • long-term follow-up

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Kawaguchi, H. (2026). Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation. Expert Opinion on Biological Therapy, 26(8), 737–743. https://doi.org/10.1080/14712598.2026.2710868

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Hiroshi Kawaguchi.

What is the DOI of this paper?

10.1080/14712598.2026.2710868, permanently at https://doi.org/10.1080/14712598.2026.2710868. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.